Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2
Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the safety and efficacy of RGN-259 Ophthalmic
Solutions to placebo for the treatment of the signs and symptoms of dry eye.